Found 10 results
Name | Type of Offering | Accepted Date |
---|---|---|
Memgen, Inc.
See All Filings
|
D | 2022-11-17 17:08:30 |
Amount To Be Raised
$5,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001760644
Filed Document
0001760644-22-000001
Exclusions or Exemptions
506b
Accepted Date
2022-11-17 17:08:30
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
TEXAS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Memgen, Inc.
See All Filings
|
D | 2021-12-13 13:55:41 |
Amount To Be Raised
$10,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001760644
Filed Document
0001760644-21-000001
Exclusions or Exemptions
506b
Accepted Date
2021-12-13 13:55:41
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
TEXAS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Memgen, Inc.
See All Filings
|
D/A | 2020-07-10 15:59:30 |
Amount To Be Raised
$10,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001760644
Filed Document
0001760644-20-000003
Exclusions or Exemptions
506b
Accepted Date
2020-07-10 15:59:30
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
TEXAS
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
Memgen, Inc.
See All Filings
|
D/A | 2023-06-29 19:47:19 |
Amount To Be Raised
$10,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001760644
Filed Document
0001760644-23-000001
Exclusions or Exemptions
506b
Accepted Date
2023-06-29 19:47:19
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
TEXAS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Memgen, Inc.
See All Filings
|
D/A | 2020-07-10 16:23:50 |
Amount To Be Raised
$10,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001760644
Filed Document
0001760644-20-000004
Exclusions or Exemptions
506b
Accepted Date
2020-07-10 16:23:50
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
TEXAS
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
Memgen, LLC
See All Filings
|
D | 2019-09-23 15:57:11 |
Amount To Be Raised
$5,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001760644
Filed Document
0001760644-19-000001
Exclusions or Exemptions
506b
Accepted Date
2019-09-23 15:57:11
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
TEXAS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Memgen, LLC
See All Filings
|
D | 2020-06-02 14:56:29 |
Amount To Be Raised
$10,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001760644
Filed Document
0001760644-20-000001
Exclusions or Exemptions
506b
Accepted Date
2020-06-02 14:56:29
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
TEXAS
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
Memgen, Inc.
See All Filings
|
D/A | 2021-12-13 17:55:18 |
Amount To Be Raised
$10,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001760644
Filed Document
0001760644-21-000002
Exclusions or Exemptions
506b
Accepted Date
2021-12-13 17:55:18
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
TEXAS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Memgen, LLC
See All Filings
|
D | 2018-12-04 13:35:14 |
Amount To Be Raised
$1,900,000
Associated Brokers / Dealers
N/A
CIK Number
0001760644
Filed Document
0001760644-18-000001
Exclusions or Exemptions
506b
Accepted Date
2018-12-04 13:35:14
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
TEXAS
Revenue or Assets
No Revenues
Type of Security
Equity
|
||
Memgen, Inc.
See All Filings
|
D | 2024-12-10 09:34:34 |
Amount To Be Raised
$10,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001760644
Filed Document
0001760644-24-000001
Exclusions or Exemptions
506b
Accepted Date
2024-12-10 09:34:34
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
TEXAS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|